GALNT9 and neoplasm: To test this hypothesis, we collected peripheral blood from rb1Δ/Δp53Δ/Δ‐scramble and rb1Δ/Δp53Δ/Δ‐Galnt9‐KD tumor‐bearing mice to evaluate their platelet activation status (Figure 6c).